Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/74862
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNgian, G.-
dc.contributor.authorSahhar, J.-
dc.contributor.authorProudman, S.-
dc.contributor.authorStevens, W.-
dc.contributor.authorWicks, I.-
dc.contributor.authorVan Doornum, S.-
dc.date.issued2012-
dc.identifier.citationAnnals of the Rheumatic Diseases, 2012; 71(12):1980-1983-
dc.identifier.issn1468-2060-
dc.identifier.issn1468-2060-
dc.identifier.urihttp://hdl.handle.net/2440/74862-
dc.description.abstractOBJECTIVES To determine the prevalence of coronary heart disease (CHD) and cardiovascular risk factors in a well-characterised cohort of systemic sclerosis (SSc) patients, and to compare this with the general population. METHODS A cross-sectional study of the prevalence of CHD and cardiovascular risk factors in participants in the Australian Scleroderma Cohort Study was performed. Controls were drawn from the 2007–8 National Health Survey (NHS) and the Australian Diabetes, Obesity and Lifestyle Study (AusDiab). OR and 95% CI were calculated to determine the prevalence of CHD and cardiovascular risk factors in SSc patients compared with controls. RESULTS Data were available for 850 SSc patients (86% female), 15 787 NHS participants (53% female) and 8802 AusDiab participants (56% female). Adjusted for age and gender, the OR of CHD in SSc patients was 1.9 (95% CI 1.4 to 2.4) compared with controls from AusDiab and 2.0 (95% CI 1.5 to 2.5) compared with controls from the NHS. The OR of CHD increased to 3.2 (95% CI 2.3 to 4.5) for SSc patients compared with controls from AusDiab after further adjustment for cardiovascular risk factors. Hypercholesterolaemia, diabetes mellitus and obesity were significantly less prevalent in the SSc cohort than in AusDiab. Within the SSc cohort, the presence of pulmonary arterial hypertension was associated with CHD. CONCLUSIONS This is the first report of an increased prevalence of CHD in SSc patients. Further studies are required to determine the relative contribution of scleroderma-specific factors such as microvascular disease to the development of CHD.-
dc.description.statementofresponsibilityGene-Siew Ngian, Joanne Sahhar, Susanna M Proudman, Wendy Stevens, Ian P Wicks, Sharon Van Doornum-
dc.language.isoen-
dc.publisherBMJ Group-
dc.rightsCopyright status unknown-
dc.source.urihttp://dx.doi.org/10.1136/annrheumdis-2011-201176-
dc.subjectHumans-
dc.subjectCardiovascular Diseases-
dc.subjectCoronary Disease-
dc.subjectScleroderma, Systemic-
dc.subjectHealth Surveys-
dc.subjectPrevalence-
dc.subjectRisk Factors-
dc.subjectCohort Studies-
dc.subjectCross-Sectional Studies-
dc.subjectAdult-
dc.subjectAged-
dc.subjectMiddle Aged-
dc.subjectAustralia-
dc.subjectFemale-
dc.subjectMale-
dc.titlePrevalence of coronary heart disease and cardiovascular risk factors in a national cross-sectional cohort study of systemic sclerosis-
dc.typeJournal article-
dc.identifier.doi10.1136/annrheumdis-2011-201176-
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/1023407-
pubs.publication-statusPublished-
dc.identifier.orcidProudman, S. [0000-0002-3046-9884]-
Appears in Collections:Aurora harvest
Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.